Vicarious Surgical Inc. (RBOT)
NYSE NYSE Primary 
XMIL 
Vicarious Surgical Inc. (RBOT) Q3 2025 Earnings Call Transcript
Vicarious Surgical Inc. ( RBOT ) Q3 2025 Earnings Call November 12, 2025 4:30 PM EST Company Participants Stephen From - CEO & Director Sarah Romano - CFO & Treasurer Conference Call Participants Marissa Bych - Gilmartin Group LLC Joshua Jennings - TD Cowen, Research Division Benjamin Haynor - Lake Street Capital Markets, LLC, Research Division Presentation Operator Good afternoon. Thank you for attending the Vicarious Surgical's 2025 Third Quarter Earnings Call.
Vicarious Surgical Inc. (RBOT) Q2 2025 Earnings Call Transcript
Vicarious Surgical Inc. (NYSE:RBOT ) Q2 2025 Earnings Conference Call August 12, 2025 4:30 AM ET Company Participants Adam David Sachs - Co-Founder, President & Director Sarah Romano - CFO & Treasurer Stephen From - CEO & Director Conference Call Participants Adam Carl Maeder - Piper Sandler & Co., Research Division Eric Evan Anderson - TD Cowen, Research Division Ryan Benjamin Zimmerman - BTIG, LLC, Research Division Marissa Elizabeth Bych - Gilmartin Group LLC Operator Good afternoon. Thank you for attending the Vicarious Surgical's 2025 Second Quarter Earnings Call.
Vicarious Surgical Inc. (RBOT) Q1 2025 Earnings Call Transcript
Vicarious Surgical Inc. (NYSE:RBOT ) Q1 2025 Results Conference Call May 12, 2025 4:30 PM ET Company Participants Webb Campbell - Investor Relations Adam Sachs - Co-Founder and CEO Sarah Romano - CFO Conference Call Participants Eric Anderson - TD Cowen Operator Hello everyone, and welcome to the Vicarious Surgical's 2025 First Quarter Earnings Call. My name is Nadia, and I'll be coordinating the call today.
What Makes D8 (RBOT) a New Buy Stock
D8 (RBOT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Vicarious Surgical Inc. (RBOT) Q4 2024 Earnings Call Transcript
Vicarious Surgical Inc. (NYSE:RBOT ) Q4 2024 Earnings Conference Call March 17, 2025 4:30 PM ET Company Participants Kaitlyn Brosco - Director-IR Adam Sachs - Co-Founder and CEO Randy Clark - President Conference Call Participants Ryan Zimmerman - BTIG Adam Maeder - Piper Sandler Josh Jennings - Cowen Operator Good afternoon. Thank you for attending the Vicarious Surgical's 2024 Fourth Quarter and Full Year Earnings Call.
Vicarious Surgical Inc. (RBOT) Q3 2024 Earnings Call Transcript
Vicarious Surgical Inc. (NYSE:RBOT ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Kaitlyn Brosco – Director-Investor Relations Adam Sachs – Co-Founder and Chief Executive Officer Bill Kelly – Chief Financial Officer Conference Call Participants Adam Maeder – Piper Sandler Operator Hello, everyone, and welcome to Vicarious Surgical's Third Quarter 2024 Earnings Call. My name is Lydia and I'll be your operator today.
Vicarious Surgical Inc (RBOT) Q2 2024 Earnings Call Transcript
Vicarious Surgical Inc (NYSE:RBOT ) Q2 2024 Results Conference Call August 12, 2024 4:30 PM ET Company Participants Kaitlyn Brosco - IR Bill Kelly - CFO & Treasurer Adam Sachs - Co-Founder, CEO & Director Conference Call Participants Eric Anderson - TD Cowen Andrew Ranieri - Morgan Stanley Ryan Zimmerman - BTIG Operator Good afternoon. Thank you for attending the Vicarious Surgical's 2024 Second Quarter Earnings Call.
Vicarious Surgical (RBOT) Partners LSU Health New Orleans
Vicarious Surgical (RBOT) teams up with LSU Health New Orleans to advance its V1.0 surgical robot. It aims to file for FDA approval by 2026.
